Global Industry Analysts, Inc., Oct 2011, Pages: 373
Radiopharmaceuticals - Global Strategic Business Report This report analyzes the US and the European markets for Radiopharmaceuticals in US$ Million by the following Product Segments: Diagnostic
Global Industry Analysts, Inc., Feb 2012, Pages: 450
) II-98
Table 24: World Recent Past, Current & Future Analysis for
Diagnostic Radiopharmaceuticals by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan
Espicom Business Intelligence Ltd, Aug 2011, Pages: 290
markets and how is this influencing developers?
- Which European company is developing nanoprobes which identify the expression of the HER2 protein and with whom is it collaborating?
- Which US company
TriMark Publications, May 2011, Pages: 252
America
8. Nuclear Cardiology: Market Analysis
8.1 Global Utilization of Nuclear Cardiology
8.1.1 Future of Global Nuclear Cardiology Utilization
8.1.2 Utilization of Nuclear Cardiology Procedures
TriMark Publications, July 2011, Pages: 225
.3.9.1 Opportunities for the Providers of PET and PET/CT
5.3.10 Medicare Reimbursement for PET Procedures
5.3.10.1 Coding
5.3.10.2 Reimbursement
5.3.10.3 Payment for Diagnostic Radiopharmaceuticals
5.3.11 U.S
TriMark Publications, May 2011, Pages: 1250
and market data are also included. To complete the analysis of the European market, this report also reviews other factors which are instrumental in shaping the future direction of Europe's medical imaging sector
Global Industry Analysts, Inc., Sep 2011, Pages: 726
Corporation (Japan) 121
Toshiba America Medical Systems, Inc. (US) 122
9. GLOBAL MARKET PERSPECTIVE 123
Table 2: World Recent Past, Current and Future Analysis for
Bioimaging Technologies by Geographic
GlobalData, Nov 2011, Pages: 68
research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Industry Experts, Feb 2012, Pages: 153
Analysis by Global Region
6.2.1 Orthopedics
Chart 3: Global Market Analysis of Tissue Engineering in Orthopedic Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest
Decision Resources, Inc., Jan 2010, Pages: 46
. In the last four years, which companies have dropped out of the ranks of Midsize Pharma and which companies have become Midsize Pharma firms? What can this analysis tell us about the future pool of Midsize
Decision Resources, Inc., Feb 2011, Pages: 37
:
Geographies: Asia Pacific; Europe; United States; Brazil, Russia, India, China, Mexico, Turkey (BRIC-MT); Middle East and North Africa (MENA); North America; Japan; Central and Eastern Europe (CEE
TriMark Publications, May 2011, Pages: 239
.17.2 U.S. Market for Computed Tomography (CT) 76
3.17.3 U.S. Market for Multi-Slice CT Scanners 77
3.17.4 U.S. Market for SPECT and PET Radiopharmaceuticals 78
3.17.5.1 Medicare Payment for SPECT/CT
Espicom Business Intelligence Ltd, July 2007, Pages: 306
Highlights (in US$)
AVID RADIOPHARMACEUTICALS
Clinical study of PET imaging with AV-1 in patients with AD
Agreements
MDS Nordion
Bayer Schering Pharma AG
Development Pipeline
Intellectual Property
Funding
Industry Experts, March 2011, Pages: 264
United States Bioinformatics Market Share (%) by Application Segment – Biopharma & Diagnostics, Genomics, Agriculture, Chemicals, Environmental & Other
EUROPE
Chart 34: European Bioinformatics Market Analysis
GlobalData, March 2012, Pages: 101
. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections
GlobalData, Dec 2010, Pages: 65
of the Month
5 Deal Summary by Geography
5.1 Medical Equipment, North America Region Deals, November 2010
5.1.1 North America – Deals of the Month
5.2 Medical Equipment, European Region, Deals, November 2010
Business Monitor International, June 2011, Pages: 87
size, but compares favourably with other Western European markets in terms of per-capita expenditure. High value patented medicines dominate the market and account for around three-quarters of sales
Espicom Business Intelligence Ltd, June 2010, Pages: 248
of patent protection on several major products in the coming period, and resolution of the biosimilar regulatory issue in the US, has to be offset against price reduction pressures driven by the ongoing
Global Industry Analysts, Inc., Oct 2010, Pages: 278
, Inc. (USA) 62
11. GLOBAL MARKET PERSPECTIVE 63
Table 6: World Recent Past, Current & Future Analysis for
Nuclear
Global Industry Analysts, Inc., Oct 2011, Pages: 261
. INDUSTRY OVERVIEW 5
Recession & Medical Imaging Equipment Market 5
Nuclear medicine - An Overview 5
A Key Application of the ‘Nuke' Industry 6
3. GLOBAL MARKET ANALYSIS 7
Global Market Review 7
US
